Ocular side effects associated with systemic isotretinoin

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 23, Issue 3, 2004, Pages 189-195

  Oner, Ayse ^a   Ferahbas, Ayten ^a   Karakucuk, Sarper ^a   Utas, Serap ^a   Karaman, Berrin ^a   Kutlugun, Caner ^a   Somdas, Mehmet ^a   Mirza, Ertugrul ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Isotretinoin; Ocular side effects

Indexed keywords

ISOTRETINOIN;

ACNE; ADOLESCENT; ADULT; ANTERIOR EYE SEGMENT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR VISION; COLOR VISION TEST; CONJUNCTIVA; CONJUNCTIVITIS; CONTACT LENS; CONTACT LENS INTOLERANCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY EYE; EYE IRRITATION; EYE REFRACTION; EYE TOXICITY; FARNSWORTH MUNSELL 100 HUE COLOR TEST; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; MICROBIOLOGICAL EXAMINATION; NOSE ALA; OCULAR PRURITUS; OPHTHALMOSCOPY; SCHIRMER TEST; STAPHYLOCOCCUS; SYSTEMIC THERAPY; TEAR FILM; TEAR FILM BREAKING UP TIME; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS;

EID: 4944233447     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.1081/CUS-200035368     Document Type: Article

References (13)

1. Gold JA, Shupack JL, Nemec MA. Ocular side effects of the retinoids. Int J Dermatol 1989; 28:218-225.
2. Hanson N, Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg 2001; 20:166-183.
3. Gross EG, Helfgott MA. Retinoids and the eye. Dermatol Clin 1992; 10:521-531.
4. Caffery BE, Josephson JE. Ocular side effects of isotretinoin therapy. J Am Optom Assoc 1988; 59:221-224.
5. Lambert RW, Smith RE. Pathogenesis of blepharoconjunctivitis complicating 13-cis-retinoic acid(isotretinoin) therapy in a laboratory model. Invest Ophthalmol Vis Sci 1988; 29:1559-1564.
6. Kremer I, Gaton DD, David M, Gaton E, Shapiro A. Toxic effects of systemic retinoids on meibomian glands. Ophthalmic Res 1994; 26:124-128.
7. Egger SF, Huber-Spitzy V, Bohler K, Scholda C. Isotretinoin administration in treatment of acne vulgaris. A prospective study of the kind and extent of ocular complications. Ophthalmologe 1995; 92:17-20.
8. Bozkurt B, Irkec MT, Atakan N, Orhan M, Geyik PO. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol 2002; 12:173-176.
9. Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland morphology and tear osmolarity: changes with Accutane therapy. Cornea 1991; 10:286-290.
10. Fraunfelder FT, La Braico JM, Meyer SM. Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol 1985; 100:534-537.
11. Heuberger A, Buchi ER. Irreversible cataract as a possible side effect of isotretinoin. Klin Monatsbl Augenheilkd 1994; 204:465-467.
12. Weleber RG, Denman ST, Hanifin JM, Cunningham WJ. Abnormal retinal function associated with isotretinoin therapy for acne. Arch Ophthalmol 1986; 104:831-837.
13. Brown RD, Grattan CE. Visual toxicity of synthetic retinoids. Br J Ophthalmol 1989; 73:286-288.